Recent advances in devices for mechanical thrombectomy.

A direct first pass aspiration technique (ADAPT) Balloon Guide Catheter (BGC) Mechanical Thrombectomy (MT) TICI score emboli in new territory (ENT) first pass effect (FPE) intra venous thrombolysis (IVT) large vessel occlusion (LVO) stent retriever (SR)

Journal

Expert review of medical devices
ISSN: 1745-2422
Titre abrégé: Expert Rev Med Devices
Pays: England
ID NLM: 101230445

Informations de publication

Date de publication:
Jul 2020
Historique:
pubmed: 20 6 2020
medline: 3 10 2020
entrez: 20 6 2020
Statut: ppublish

Résumé

Acute ischemic stroke (AIS) secondary to the occlusion of a large intracranial vessel (LVO) is a recognized public health problem. Mechanical thrombectomy (MT) has gained full acceptance: Class A, Level 1 in 2015 after the publication of numerous trials. Further meta-analyses have scrutinized extensively those results and international recommendations and guidelines have been given. Nevertheless, multiple-specific points remain to be clarified and are or will be under investigations. This review of the most recent literature (mostly publications after 2015) will cover the actual common practice for MT, especially focusing on the devices available (and their validation), how they are commonly used, relate the most relevant results, and detail some emerging technologies. The authors will express their own view on the current practice and emphasize on the areas where questions remain and hypothesize what specific improvements are necessary and prone to occur.

Identifiants

pubmed: 32552093
doi: 10.1080/17434440.2020.1784004
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

697-706

Auteurs

Raphaël Blanc (R)

Interventional Neuroradiology Department, Fondation Rothschild Hospital , Paris, France.
Université Paris Denis Diderot, Sorbonne Paris Cite , Paris, France.
Laboratory of Vascular Translational Science, U1148 Institut National de la Santé et de la Recherche Médicale (INSERM) , Paris, France.

Simon Escalard (S)

Interventional Neuroradiology Department, Fondation Rothschild Hospital , Paris, France.

Humain Baharvadhat (H)

Interventional Neuroradiology Department, Fondation Rothschild Hospital , Paris, France.

Jean Philippe Desilles (JP)

Interventional Neuroradiology Department, Fondation Rothschild Hospital , Paris, France.
Université Paris Denis Diderot, Sorbonne Paris Cite , Paris, France.
Laboratory of Vascular Translational Science, U1148 Institut National de la Santé et de la Recherche Médicale (INSERM) , Paris, France.

William Boisseau (W)

Interventional Neuroradiology Department, Fondation Rothschild Hospital , Paris, France.

Robert Fahed (R)

Department of Medicine/Division of Neurology, Department of Medical Imaging/Division of Radiology, The Ottawa Hospital , Ottawa, Ontario, Canada.

Hocine Redjem (H)

Interventional Neuroradiology Department, Fondation Rothschild Hospital , Paris, France.

Gabriele Ciccio (G)

Interventional Neuroradiology Department, Fondation Rothschild Hospital , Paris, France.

Stanislas Smajda (S)

Interventional Neuroradiology Department, Fondation Rothschild Hospital , Paris, France.

Benjamin Maier (B)

Interventional Neuroradiology Department, Fondation Rothschild Hospital , Paris, France.

François Delvoye (F)

Interventional Neuroradiology Department, Fondation Rothschild Hospital , Paris, France.

Solène Hebert (S)

Interventional Neuroradiology Department, Fondation Rothschild Hospital , Paris, France.

Mikael Mazighi (M)

Interventional Neuroradiology Department, Fondation Rothschild Hospital , Paris, France.
Université Paris Denis Diderot, Sorbonne Paris Cite , Paris, France.
Laboratory of Vascular Translational Science, U1148 Institut National de la Santé et de la Recherche Médicale (INSERM) , Paris, France.

Michel Piotin (M)

Interventional Neuroradiology Department, Fondation Rothschild Hospital , Paris, France.
Université Paris Denis Diderot, Sorbonne Paris Cite , Paris, France.
Laboratory of Vascular Translational Science, U1148 Institut National de la Santé et de la Recherche Médicale (INSERM) , Paris, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH